Research programme: metabotropic glutamate receptor antagonists - Banyu
Latest Information Update: 24 Jan 2008
At a glance
- Originator Banyu
- Class
- Mechanism of Action Metabotropic glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Neurological disorders; Pain
Most Recent Events
- 21 Sep 2005 Preclinical trials in Anxiety disorders in Japan (unspecified route)
- 21 Sep 2005 Preclinical trials in Neurological disorders in Japan (unspecified route)
- 21 Sep 2005 Preclinical trials in Pain in Japan (unspecified route)